The ErbB1-dependent effect of recombinant epidermal growth factor (rEGF) against lapatinib-induced cytotoxicity in Caco-2 human intestinal cells / Raja Nur Firzanah Syaza Raja Sharin ... [et al.]

Lapatinib, an orally administered dual ErbB1 and ErbB2 tyrosine kinase inhibitor, is an FDA-approved treatment for ErbB2-positive breast tumour. However, diarrhoea is one of the major drawbacks for this treatment. Incidence of lapatinib-induced diarrhoea (LID) has been reported as high as 58-78% of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Raja Sharin, Raja Nur Firzanah Syaza (Yazar), Wan Mohamad Zain, Wan Nor I'zzah (Yazar), Khan, Jesmine (Yazar), Ibahim, Mohammad Johari (Yazar)
Materyal Türü: Kitap
Baskı/Yayın Bilgisi: Universiti Teknologi MARA, Pulau Pinang, 2022-09.
Konular:
Online Erişim:Link Metadata
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

Link Metadata

3rd Floor Main Library

Detaylı Erişim Bilgileri 3rd Floor Main Library
Yer Numarası: A1234.567
Kopya Bilgisi 1 Kütüphanede